Efficacy of vancomycin plus levofloxacin combination therapy for refractory pericarditis due to multiresistant Streptococcus pneumoniae.
Safdar
Amar
A
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D004359:Drug Therapy, Combination; D006801:Humans; D064704:Levofloxacin; D008297:Male; D015242:Ofloxacin / Q000627:therapeutic use*; D010493:Pericarditis / Q000188:drug therapy*; D011008:Pneumococcal Infections / Q000188:drug therapy*; D013296:Streptococcus pneumoniae / Q000254:growth & development*; D014640:Vancomycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D064704:Levofloxacin; D014640:Vancomycin; D015242:Ofloxacin